Assessment of Medication Dosage Adjustment in Hospitalized Patients With Chronic Kidney Disease.

chronic kidney disease dose adjustment medication errors renal impairment

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
20 Feb 2021
Historique:
entrez: 26 3 2021
pubmed: 27 3 2021
medline: 27 3 2021
Statut: epublish

Résumé

Background Inappropriate medication dosing can cause adverse drug reactions or ineffective therapy due to declined renal function in patients with renal insufficiency. This necessitates proper renal dose adjustment. This study was proposed to evaluate medication dosage adjustment in hospitalized chronic kidney disease (CKD) patients. Methods This study included all CKD patients hospitalized between May 1, 2019, and April 25, 2020, at the Institute of Kidney Disease, Peshawar, Pakistan. The estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease formula, and dose appropriateness was established by evaluating practice with relevant reference books. Results Of the total 1,537 CKD patients, 231 (15.03%) had evidence of dosing error, which was considered for final analysis. Overall, 1,549 drugs were prescribed; 480 (30.99%) drugs required dose adjustment, of which 196 (40.42%) were adjusted properly and the remaining 286 (59.58%) were unadjusted. The most common unadjusted drugs were meropenem, cefepime, ciprofloxacin, and rosuvastatin, whereas captopril, aspirin, bisoprolol, pregabalin, and levofloxacin had the highest percentage of adjusted drugs. On multivariate logistic regression, the number of drugs requiring dosing adjustments and obstructive nephropathy were found to be statistically significant factors that increased the likelihood of the medication dosing errors: a unit increase in the number of drugs requiring dose adjustment increases 5.241 times the likelihood of dosing error. Similarly, the presence of obstructive nephropathy (OR: 0.383; 95% Cl: 0.153-0.960; p = 0.041) was found to be significantly associated with dosing error after adjustment for potential confounding factors. Conclusion The dosing of more than half of the prescribed drugs that required adjustment in CKD patients was not adjusted, which showed that medication dosing errors were high. This highlights the importance of medication prescription according to guidelines in these patients to improve the outcomes of pharmacotherapy.

Identifiants

pubmed: 33767933
doi: 10.7759/cureus.13449
pmc: PMC7982869
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e13449

Informations de copyright

Copyright © 2021, Hassan et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Nephrol. 2009 Jul-Aug;22(4):497-501
pubmed: 19662605
Am J Ther. 2016 Jul-Aug;23(4):e1004-8
pubmed: 24263162
Ther Clin Risk Manag. 2016 Oct 12;12:1517-1524
pubmed: 27785039
PLoS One. 2020 Mar 24;15(3):e0230512
pubmed: 32208435
Am J Kidney Dis. 1986 Jul;8(1):7-17
pubmed: 3524205
BMC Res Notes. 2014 Mar 27;7:179
pubmed: 24670059
Bull World Health Organ. 2018 Jun 1;96(6):414-422D
pubmed: 29904224
BMC Nephrol. 2014 Jun 13;15:90
pubmed: 24927636
J Nepal Health Res Counc. 2014 Jan;12(26):54-8
pubmed: 25574986
Drugs Aging. 2015 May;32(5):391-400
pubmed: 25925940
Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):908-12
pubmed: 17464934
Int J Qual Health Care. 2003 Aug;15(4):331-5
pubmed: 12930048
Ann Pharmacother. 2005 Jan;39(1):22-7
pubmed: 15546945
PLoS One. 2016 Jul 01;11(7):e0158677
pubmed: 27367594
Clin Biochem Rev. 2011 May;32(2):69-73
pubmed: 21611079
S Afr Med J. 2010 May 04;100(5):304-6
pubmed: 20460024
Kidney Int. 2009 Dec;76(11):1123-5
pubmed: 19910946
Am Fam Physician. 2007 May 15;75(10):1487-96
pubmed: 17555141
PLoS One. 2015 Jun 08;10(6):e0128237
pubmed: 26053481
Intern Med J. 2003 Jan-Feb;33(1-2):10-3
pubmed: 12534872
Pharm Pract (Granada). 2019 Jan-Mar;17(1):1304
pubmed: 31015868
Mayo Clin Proc. 2015 May;90(5):633-45
pubmed: 25771152
BMC Nephrol. 2015 Oct 07;16:158
pubmed: 26446847
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1254-60
pubmed: 16804098
Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1085-1095
pubmed: 29934432
Kidney Int. 2009 Dec;76(11):1192-8
pubmed: 19759525

Auteurs

Zair Hassan (Z)

Cardiology, Lady Reading Hospital, Peshawar, PAK.

Iftikhar Ali (I)

Pharmacy, Paraplegic Center, Peshawar, PAK.

Arslan R Ullah (AR)

Internal Medicine, Northwest General Hospital & Research Centre, Peshawar, PAK.

Raheel Ahmed (R)

Nephrology, Institute of Kidney Diseases, Peshawar, PAK.

Adnan Zar (A)

Internal Medicine, Lady Reading Hospital, Peshawar, PAK.

Irfan Ullah (I)

Internal Medicine, Kabir Medical College, Peshawar, PAK.

Shakeel Rehman (S)

Pharmacy, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Peshawar, PAK.

Aziz Ullah Khan (AU)

Pharmacy, Lady Reading hospital, Peshawar, PAK.

Rizwan Ullah (R)

Cardiology, Lady Reading Hospital, Peshawar, PAK.

Muhammad Hanif (M)

Internal Medicine, Khyber Medical College Peshawar, Hayatabad Medical Complex, Peshawar, PAK.

Classifications MeSH